Eagle Pharmaceuticals, Inc. Additional Paid in Capital
Eagle Pharmaceuticals, Inc. had Additional Paid in Capital of $373.83 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2023-08-09
- 2023-06-30: Additional Paid in Capital $373.83M.
- 2023-03-31: Additional Paid in Capital $369.80M.
- 2022-12-31: Additional Paid in Capital $366.26M.
- 2022-09-30: Additional Paid in Capital $362.16M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2023-06-30 | $373.83M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $369.80M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $366.26M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $362.16M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $358.38M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $328.77M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $325.78M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $320.57M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $316.25M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $312.32M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $305.40M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $296.20M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $291.43M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $285.04M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $278.52M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $273.15M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $267.48M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $262.08M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $256.46M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $251.88M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $245.47M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $237.06M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $233.64M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $229.66M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $225.89M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $220.20M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $213.87M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $206.47M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $202.73M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $200.31M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $197.44M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $195.94M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $194.60M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $192.85M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $137.58M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $137.26M 10-K · filed 2016-02-29 | |
| 2014-06-30 | $136.97M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $136.81M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $14.20M 10-K · filed 2014-12-22 | $14.20M 10-Q · filed 2014-05-15 |